0001998028-23-000001.txt : 20231024 0001998028-23-000001.hdr.sgml : 20231024 20231024171448 ACCESSION NUMBER: 0001998028-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20231024 DATE AS OF CHANGE: 20231024 EFFECTIVENESS DATE: 20231024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Legacy Pharma Invest LP CENTRAL INDEX KEY: 0001998028 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495554 FILM NUMBER: 231343407 BUSINESS ADDRESS: STREET 1: 135 YORKVILLE AVENUE, FLOOR 9 CITY: TORONTO STATE: A6 ZIP: M5R 0C7 BUSINESS PHONE: 416-925-6609 MAIL ADDRESS: STREET 1: 135 YORKVILLE AVENUE, FLOOR 9 CITY: TORONTO STATE: A6 ZIP: M5R 0C7 D 1 primary_doc.xml X0708 D LIVE 0001998028 Legacy Pharma Invest LP 135 YORKVILLE AVENUE, FLOOR 9 TORONTO A6 ONTARIO, CANADA M5R 0C7 416-925-6609 ONTARIO, CANADA None None Limited Partnership true 2023 NA Legacy Pharma Invest GP Inc. 135 YORKVILLE AVENUE, FLOOR 9 TORONTO A6 ONTARIO, CANADA M5R 0C7 Promoter General Partner of Issuer Andrew Lapham 135 YORKVILLE AVENUE, FLOOR 9 TORONTO A6 ONTARIO, CANADA M5R 0C7 Executive Officer Director Director, Chief Executive Officer of GP of Issuer James Albrecht 135 YORKVILLE AVENUE, FLOOR 9 TORONTO A6 ONTARIO, CANADA M5R 0C7 Executive Officer Director Director, Chief Financial Officer and Chief Operating Officer of GP of Issuer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Indefinite 0 Indefinite false 0 0 0 0 false Legacy Pharma Invest LP /s/ Andrew Lapham Andrew Lapham Director, Chief Executive Officer of GP of Issuer 2023-10-24